Arthroplasty-Associated Infections 

  • Author: Rajesh Malhotra, MBBS, MS; Chief Editor: William L Jaffe, MD   more...
 
Updated: Sep 27, 2011
 

Overview

Infection, though an uncommon complication of arthroplasty, may be among the most devastating complications for the patient, as well as for the surgeon. The economic consequences associated with treating periprosthetic infections are substantial.[1, 2, 3]

Revision procedures for infection are associated with a longer operating time, greater blood loss, and more frequent complications, along with increases in total number of hospitalizations, duration of hospitalization, total number of operations, total hospital costs, and total outpatient visits and charges. When compared with revisions for aseptic loosening or primary total hip arthroplasties (THAs), revisions for sepsis are associated with significantly greater use of hospital and physician resources.[3]

Currently, the reported infection rate after arthroplasty is about 1%.[4] Kurtz et al quantified the current and historical incidence of periprosthetic infection associated with hip and knee arthroplasty in the United States using the Nationwide Inpatient Sample, as well as corresponding hospitalization charges and length of stay, and found that the rate of infected knee arthroplasties was 0.92%, significantly greater than the rate of infected hip arthroplasties (0.88%).[5]

The number of primary and revision procedures has been projected to expand dramatically over the next 25 years[6] ; accordingly, the infection burden on patients, clinicians, and society as a whole will also increase. Methods of preventing, diagnosing, and treating infection must be continually improved in order to reduce the cost and complications of total joint arthroplasty.

The goals for management of a septic prosthetic failure are to eradicate the infection and to provide a functional limb. The various modalities employed to manage arthroplasty-associated infections include long-term antibiotic suppression, débridement, exchange arthroplasty, and arthrodesis. Amputation is done as a desperate procedure in cases of life-threatening sepsis.

There is a need for both improved diagnostic methods and more efficient treatment protocols. Molecular diagnostic methods, such as polymerase chain reaction (PCR) testing, have been associated with high false-positive rates and are still not recommended for routine clinical use. Addressing bone defects during reimplantation is an area that also requires further research.

The problems of conducting randomized studies in the setting of a septic prosthetic failure are a major deterrent to the evolution of treatment protocols. Foolproof intraoperative diagnostic techniques, improved implant designs, and better local antibiotic delivery systems must be developed to face the menace of infection associated with joint replacement surgery.

Gains may be achieved not only by developing newer approaches but also by using currently available approaches more effectively. For example, in one study, culture of samples obtained via sonication of prostheses was more sensitive than conventional periprosthetic-tissue culture for microbiologic diagnosis of prosthetic hip and knee infection, especially in patients who had received antimicrobial therapy within the 14 days preceding surgery.[7]

In a meta-analysis, antigranulocyte scintigraphy with monoclonal antibodies had a reasonably high discriminating ability with respect to identification of prosthesis infection in patients who underwent total joint arthroplasty.[8]

The use of cefuroxime-impregnated cement was shown to be effective in the prevention of early to intermediate deep infection after primary total knee arthroplasty (TKA) performed with perioperative systemic antibiotic prophylaxis but without any so-called clean-air measures.[9] This measure may be particularly helpful in developing nations, where more and more arthroplasties are now being performed.

Additional pathogens are being found to cause prosthetic joint infections. A Swiss study drew attention toward infection by Propionibacterium acnes; a median of 10 biopsies, a 14-day incubation period, and histopathologic examination were needed to establish the association.[10]

Thus, the future of management of arthroplasty-associated infections lies in devising ways to prevent infections, developing investigations that allow early detection, and minimizing both the emergence of new pathogens and the spread of antibiotic resistance among existing pathogens.

Next

Classification

Tsukayama et al classified arthroplasty-associated infections into 4 types according to the most common presenting patterns; they also recommended treatments for each type, as follows[11] :

  • Type I - Positive intra operative cultures in a hip undergoing revision for aseptic loosening, without previous indications of infection; 2 positive cultures out of a minimum of 5 are necessary to make the diagnosis; revision surgery in these patients is already performed for a presumed aseptic failure when the culture results become available
  • Type II - Early postoperative infection occurring within 1 month of the index procedure; classic symptoms and signs of infection may be present; the infection may be either superficial (because of fat necrosis) or deep seated, and the 2 must be distinguished
  • Type III - Acute infection in a well-functioning joint; often, there is a recent history of an infection elsewhere in the body or an invasive procedure (eg, tooth extraction); immunocompromised patients are susceptible to these infections, which may be preventable if antibiotic prophylaxis is routinely provided when these patient undergo total joint arthroplasty
  • Type IV - Deep infection that presents insidiously at least 1 month and as much as 2 years after the index procedure; often, there are no systemic symptoms, and persistent pain may be the only local problem
Previous
Next

Etiology

The factors influencing the occurrence of arthroplasty-associated infections include host factors (ie, those related to the patient), the operating room (OR) environment, the techniques and materials employed in the surgical procedure (ie length of surgical time), the characteristics of the infecting organism, and the use of preoperative antibiotics.[12]

Host factors

Immunocompromised status, rheumatoid arthritis, and diabetes mellitus are some of the most important comorbid conditions associated with an increased risk of infection in a patient undergoing arthroplasty.

Malnutrition has been defined by many authors as a total white blood cell (WBC) count lower than 1500/µL and an albumin level lower than 3.5 mg/dL.[13] Malnourished patients have an increased chance of wound complications.[14] Hence, it is imperative to build up the patient’s nutritional status before the operation.

Obesity is another important factor to be considered. One study found obesity to be an independent risk factor for the development of deep sepsis after hip arthroplasty.[15] Chronic urinary tract infection and ongoing sepsis in any other part of the body also increase the risk.

Steroid use for an associated condition (eg, inflammatory arthritis or psoriasis) has been associated with increased susceptibility to infection. A previous surgical procedure on the same joint is an independent risk factor that doubles the risk of deep infection in the knee and triples the risk in the hip.[16, 17] Elderly patients and patients with comorbid conditions that require a long time for optimization before surgery are more susceptible to infection as well.[18]

Operating room environment

The number of personnel and the amount of traffic in the OR exert an influence on the incidence of infection. Accordingly, changes in the OR environment have the potential to reduce infection. For example, some people shed a large number of bacteria; they can help decrease the risk of infection by using helmet aspirator suits.

Although various commercial preparations are available for preparing the surgical site, most surgeons prefer the iodophor compounds. Shaving the area is best avoided, but if it is considered essential, it should be done immediately before the procedure. The use of an iodophor-incorporated drape has been proved to decrease infection in arthroplasty patients and is now routine in this setting.

In one study, the use of an iodophor-incorporated drape during 649 total knee arthroplasties (TKAs) was associated with an infection rate of only 0.5%.[19] In another study, the use of an iodophor-incorporated drape proved to be significantly better at preventing recolonization of the skin by bacteria than other methods of skin-site preparation were.[20]

Ultraviolet (UV) light has been employed to decrease the bacterial load in the OR. This measure adds to the cost of the procedure but has not been conclusively shown to produce a decrease in infection risk.[21]

Use of vertical laminar airflow has been found to yield a significant decrease in the bacterial load in the OR air and thereby decrease the infection rates with total hip arthroplasties (THAs). In an important study from the early 1980s, Lidwell et al concluded that laminar airflow systems and body exhaust suits independently reduced surgical infection risk by 50%.[22]

However, Miner et al, in a 2007 population survey designed to assess the efficacy of laminar flow and body exhaust suits, found no conclusive evidence to support this result.[23] The cost of laminar airflow systems and body exhaust suits is substantial, adding hundreds of dollars to the expense of each operation and complicating the environment in which the operating team works. The authors concluded that it would be worthwhile to obtain additional evidence about whether these widely used clean-air practices have a meaningful clinical benefit in today’s OR.

Surgical techniques and materials

A prolonged operating time increases the risk of infection.[24] In one population-based survey, a prolonged operating time was in fact the only statistically significant risk factor for infection.[23]

The type of implant used also influences the infection risk. For example, a large hinged knee implant increases the risk of infection. Materials such as polymethylmethacrylate (PMMA), steel, cobalt-chromium (CoCr), and polyethylene (PE) are susceptible to the formation of a biofilm by the infecting organism around the implant, which protects the pathogen from the action of antibiotics.[25]

Characteristics of infecting organisms

The virulence of the infecting organisms is an important factor to consider in planning management. Staphylococcus aureus and Staphylococcus epidermidis are the most commonly isolated organisms. Gram-negative infections are resistant to treatment and are a frequent cause of recurrence after an exchange arthroplasty.[26] Organisms that can form glycocalyx, methicillin-resistant S aureus (MRSA), group D streptococci, and enterococci are considered highly virulent.

A frequent cause of inability to isolate the organism is empirical antibiotic therapy. Other causes are infections caused by anaerobic organisms and fungi.

Trampuz et al reported the frequencies with which different pathogens cause prosthetic joint infections (see Table 1 below).[27]

Table 1: Common Pathogens Responsible for Prosthetic Joint Infections (Open Table in a new window)

Microorganism Frequency (%)
Coagulase-negative staphylococci30-43
Staphylococcus aureus12-23
Streptococci9-10
Enterococci3-7
Gram-negative bacilli3-6
Anaerobes2-4
Multiple pathogens (polymicrobial)10-12
Unknown10-11

Prosthetic joint infections are caused by pathogens living clustered together in biofilm, a highly hydrated extracellular matrix attached to the implant surface. Within the biofilm, the organisms grow either slowly or not at all; consequently, they are resistant to all growth dependent antibiotics. The bacterial cells of the biofilm organize among themselves, communicate with each other. and behave like a multicellular organism. The biofilm helps the pathogens combat external and internal forces, whether from the host immune system or from antibiotics.[27]

Use of antibiotic prophylaxis

The Surgical Infection Prevention Project and its Surgical Infection Prevention Guideline Writers Workgroup are promoting 3 major interventions to prevent surgical site infections (SSIs)[28] :

  • Proper timing of prophylactic antibiotics, so that preoperative administration occurs within 1 hour of the surgical incision
  • Correct selection of antibiotics
  • Correct duration of postoperative antibiotic administration

With increasing frequency, patients are admitted to the hospital on the day of the operation and present to the OR just before their procedure. It is therefore essential to ensure that the institution of safeguards regarding the correct surgical site and the administration of prophylactic antibiotics no more than 1 hour before surgery are implemented as components of an institutional process.[29]

The cephalosporins cefazolin and cefuroxime are considered to have equal prophylactic efficacy. Local guidelines that recommend beta-lactam agents as first-line prophylaxis should also recommend alternative drugs for those allergic to penicillin. Available evidence suggests that administering the first dose as near to the incision time as possible will reduce the likelihood of infection, whether superficial or deep.

There remains some controversy regarding the optimal duration of prophylaxis in connection with THA. The US advisory statement recommends that antimicrobial prophylaxis be administered no more than 1 hour before the incision and discontinued within 24 hours after the end of the operation.[28] However, European guidelines recommend administering a single dose no more than 30 minutes before the incision and advise considering prophylaxis for as long as 24 hours after the operation.[30, 31]

In a Dutch study, superficial and deep SSIs occurred in 2.6% of 1922 THA patients, and the highest odds ratios for infection were found in those who received prophylaxis after incision, those with an American Society of Anesthesiology score of 12, and those in whom the operating time was above the 75th percentile.[32] Prolonged prophylaxis after the end of the procedure and the use of antibiotic-impregnated cement did not contribute to fewer infections in this study.

Previous
Next

Presentation

The diagnosis of an infected total hip arthroplasty (THA) can be relatively straightforward in the presence of wound drainage, erythema, and swelling about the hip associated with the systemic symptoms of fever, chills, and generalized malaise. Unfortunately, many periprosthetic infections do not exhibit obvious signs and symptoms of infection.[33, 34]

In the absence of obvious indicators, a thorough history and a detailed examination of the patient should suggest the possibility of infection. A high index of suspicion is necessary. Often, the only symptom is the acute onset of pain in a previously well-functioning joint.

Previous
Next

Blood Tests

The erythrocyte sedimentation rate (ESR) and the C-reactive protein (CRP) level provide excellent diagnostic information for establishing the presence or absence of infection before surgical intervention in patients with pain at the site of a knee arthroplasty. ESR values higher than 35 mm/h have been associated with deep infection.[35, 36] However, the ESR is not always elevated in a chronic deep infection. When the ESR is used alone, its reported specificity and sensitivity are 0.82 and 0.86, respectively.

The CRP level usually peaks on postoperative day 2 and falls back to normal levels by 2 to 3 weeks. It is usually normal in cases of aseptic loosening but is elevated by more than 10 mg/L in cases of infection. When used along with ESR, the CRP level has a specificity of 1.00 for diagnosing periprosthetic infections.[35, 36, 37] Repeated measures of the CRP level showing a rising or falling trend are more useful for deciding on management and planning follow-up.

The total white blood cell (WBC) count may be a helpful addition. In fulminant infections, there leukocytosis with an increase in immature neutrophils may be noted. In indolent infections, the complete blood count (CBC) with differential may be normal.[4]

Previous
Next

Joint Fluid Aspiration

Aspiration of fluid from a suspected joint is highly sensitive and specific for periprosthetic infection, and some recommend that it be done routinely in the setting of an abnormal erythrocyte sedimentation rate (ESR) in a young implant.[34]

Aspiration is used to confirm a clinical suspicion of infection or to support or negate the findings of other preoperative investigations, such as the ESR and the C-reactive protein (CRP) level, which may be falsely elevated because of connective-tissue disease. An additional benefit of aspiration in instances of suspected infection is the ability to identify the organism and its antibiotic-sensitivity profile, which may influence preoperative planning and the choice of an antimicrobial agent if use of an antibiotic depot is planned.[35]

Aspiration must be performed under aseptic conditions. Contamination of the sample by skin organisms of and inoculation of organisms into the joint are the main concerns. To increase the chances of culture positivity, antibiotics should be discontinued 2 to 3 weeks before aspiration. Glucose levels and cell counts are obtained, and cultures are done on 3 samples. If all 3 samples are positive, the diagnosis is established. If 2 are positive and blood parameters are elevated, the diagnosis of infection is made; otherwise, the aspiration is repeated.

Previous
Next

Tissue Analysis

Histopathologic examination of frozen tissue samples during surgery has a low sensitivity but a high specificity for diagnosing infection.[38] Tissue from the bone-cement or prosthesis-bone interface, as well as from abnormal-appearing areas of synovial tissue, should be examined. The presence of more than 5 polymorphonuclear leukocytes per high power field is diagnostic of infection, but the presence of fewer than 5 does not suffice to rule out infection.[38]

A preoperative core biopsy provides the advantages of aspiration and tissue examination and is a useful investigation in suspected joints.[39]

Previous
Next

Plain Radiography

Plain radiographs should always be obtained when infection in a prosthetic joint is suspected, even though they are rarely diagnostic in themselves. Serial radiographs often aid in diagnosing infection. A particular difficulty is distinguishing septic loosening from aseptic loosening. Periosteal new bone formation may help in differentiating these 2 conditions; this finding has been associated with the presence of deep sepsis in total hip arthroplasty (THA) and is considered by some to be pathognomonic for this condition.[40]

More severe and longstanding cases periprosthetic infection may show evidence of implant loosening, lysis, bone resorption adjacent to the implant, areas of new bone formation, and periosteal reaction (see the image below).

Lateral radiograph showing lysis and loosening of Lateral radiograph showing lysis and loosening of prosthesis.

Progressive loosening is a worrying sign that suggests potential infection. Endosteal scalloping is highly suggestive of infective loosening. Loosening on the acetabular side is indicated by migration of the cement mantle or the socket (see the image below), protrusion, or fracture. Arthrography, sometimes done in conjunction with aspiration, can help diagnose loosening but cannot confirm infection.

Radiograph of 50-year-old patient for whom bipolarRadiograph of 50-year-old patient for whom bipolar arthroplasty was done elsewhere for displaced fracture of neck of femur. Patient came with severe pain hip 1 year after procedure. Severe osteolysis and superior migration of prosthesis are seen.
Previous
Next

Nuclear Scanning

Technetium-99m (99m Tc) and indium-111 (111 I) polyclonal antibody scans and monoclonal antibody scans have proved useful in diagnosing arthroplasty-associated infections; however, they cannot distinguish between septic and aseptic loosening.99m Tc scans are sensitive but not specific. Gallium scans are similar to99m Tc scans.

Sequential99m Tc- and111 I-labeled white blood cell (WBC) scanning is highly sensitive and specific and can be used to make the diagnosis in equivocal situations.[41] The study is considered to be positive for periprosthetic infection when there is activity on the labeled leukocyte scan but no corresponding activity in the same area of distribution on the99m Tc scan. Love et al reported a sensitivity of 100%, a specificity of 91%, and an accuracy of 95% when both imaging modalities were used to detect periprosthetic infection at the site of total joint arthroplasty.[42]

Similarly, fluorodeoxyglucose positron emission tomography (FDG-PET) scanning has shown promising results in the majority of studies for the detection of periprosthetic infection.[43, 44]

Previous
Next

Principles of Treatment

In managing a septic prosthetic failure, the goals are to eradicate the infection and to provide a functional limb. The various treatment modalities include long-term antibiotic suppression, débridement, exchange arthroplasty, and arthrodesis. Amputation is done as a desperate procedure in case of life-threatening sepsis. A concise approach to infections associated with prosthetic joints is provided in Table 2 below.[27]

Table 2. Concise Approach to Treatment of Prosthetic Joint Infections (Open Table in a new window)

Status of Prosthetic Joint Infection Treatment
Duration of symptoms < 3 wk



and



stable implant



and



absence of sinus tract



and



susceptibility to antibiotics with activity against surface-adhering microorganisms



Débridement with retention
Intact or only slightly damaged soft tissue1-stage exchange
Damaged soft tissue, abscess, or sinus tract2-stage exchange with short interval (2-4 wk), spacer
Microorganism resistant or difficult to treat*2-stage exchange with long interval (6-8 wk), no spacer
Inoperable, debilitated, or bedriddenLong-term suppressive antimicrobial treatment
No functional improvement by exchange of implantImplant removal without replacement

The Tsukayama classification of arthroplasty-associated infection into 4 types (see Classification) can help in formulating the treatment recommendations for the infection. Tsukayama et al based their treatment of infections after total hip arthroplasty (THA) on the clinical presentation—that is, positive intraoperative cultures, early postoperative infection, acute hematogenous infection, or late chronic infection. Treatment protocols have been successfully used for these 4 clinical settings.[26]

Positive intraoperative culture

Patients who have positive intraoperative cultures can be managed with intravenous (IV) administration of antibiotics for 6 weeks without operative intervention. In these patients, a revision prosthesis has already been implanted for presumed aseptic loosening before the results of the intraoperative cultures become available. Conceivably, this may be a situation for routine use of antibiotic cement in all revisions.

Early postoperative infection

Patients who had an early postoperative infection are managed with débridement, replacement of the polyethylene (PE) insert of the acetabular/tibial component, retention of the prosthesis, and IV administration of antibiotics for 6 weeks.

Removal of the original PE insert permits greater access to the site of the acetabular/tibial component for débridement and removal of a possible nidus of infection. In both the hip and the knee, removal and replacement of the PE liner are frequently necessary to provide access to the complete joint for thorough debridement, and this is the reason why arthroscopic débridement has fallen into disfavor in the knee.

Attempts are made to check the fixation of components manually. There should be no radiologic evidence of loosening. Débridement is tried once or twice, with IV antibiotics administered at an adequate dosage. Although an attempt is generally made to salvage the prosthesis, removal may be warranted in cases where infection is recalcitrant or the implants are loose. Successful results can be attained when the duration of presentation is shorter or when the pathogen is a low-virulence organism.

The success rate of irrigation and débridement in the treatment of early postoperative infection has ranged from 0% to 100%.[45, 46, 47, 48] Nolan et al reported that this procedure was successful for all of 6 infections diagnosed within 2 weeks after an index total hip arthroplasty.[45] In general, it appears that the longer that the infection has been present in the hip, the more difficult it is to eradicate it without removal of the prosthesis.

Acute hematogenous infection

Patients who have an acute hematogenous infection are also managed with débridement, replacement of the polyethylene insert, retention of the prosthesis if it is not loose, and intravenous administration of antibiotics for 6 weeks.

Late chronic infection

Patients who have a late chronic infection are managed with débridement, removal of all prosthetic components and bone cement, and either a direct 1-stage revision[49, 50] or a 2-stage exchange (see the images below).[51, 52, 53] Eradication of the infection would entail removal of components in most of these patients, and trying to salvage the prosthesis may be futile.

Stage I revision with antibiotic spacer made from Stage I revision with antibiotic spacer made from mold. Radiograph after stage I revision. Radiograph after stage I revision. Stage II revision. Bone loss at femoral side; alloStage II revision. Bone loss at femoral side; allograft used. Astemmed femoral prosthesis and allograft used forAstemmed femoral prosthesis and allograft used for bone loss. Final radiograph after stage II revision. Final radiograph after stage II revision. Final radiograph after stage II revision. Final radiograph after stage II revision.
Previous
Next

Exchange Arthroplasty

When exchange is being considered, many important factors must be taken into account. In particular, the host should be evaluated for any problems that may cause a recurrence of infection, including the following[26] :

  • Retained bone cement
  • Previous operations
  • Potential immunocompromise (patients with rheumatoid arthritis, diabetes mellitus, chronic renal insufficiency, or a malignant tumor are considered potentially immunocompromised)
  • Early postoperative infection after arthroplasty without cement

The extent of disability after component removal, the virulence of the infecting organisms, the adequacy of débridement, and the degree to which infection is controlled at local and distant sites are some of the important variables affecting the outcome of an exchange procedure. The literature suggests that infections caused by gram-negative organisms are more difficult to treat than those caused by gram-positive isolates.[54, 55, 56, 57, 58]

Removal of components can be delayed until culture sensitivities are available, unless the patient is in a toxic state. All cement must be carefully removed; image intensification may be necessary to accomplish this. The difficulty of eradicating bacteria adhering to foreign bodies has been well described,[59] as has the need to remove all hardware and cement in the treatment of periprosthetic infections.[46, 48, 58, 60, 61, 62] Periprosthetic tissue should be obtained at the time of prosthesis removal for culture and histologic examination.

If a later exchange is planned, an antibiotic-impregnated spacer or antibiotic beads should be placed after removal of the components (see the image below). An antibiotic-impregnated spacer can be made from antibiotic-loaded cement in the operating room (OR). The spacer maintains limb length and soft tissue tension and makes the definitive reimplantation procedure easier; however, there is a chance that it may fracture or dislocate.

Cement spacer application. Cement spacer application.

This device is a “dynamic” spacer, in that it allows movements and avoids muscle wasting. Initial results have been successful.[63] In place of a spacer, some authors prefer to use tobramycin beads, made with a mixture of 1.2 g of tobramycin and 20 g of polymethylmethacrylate (PMMA).[64] Antibiotics are also administered intravenously (IV) for 6 weeks, after which time a delayed exchange arthroplasty is performed.

One report has described a 2-stage exchange arthroplasty technique using an antibiotic-impregnated cement intramedullary nail, which can be easily prepared during surgery and which may provide additional stability to the knee and help it maintain its normal mechanical axis.[65] The advantages claimed for this technique include less pain between prosthesis removal and subsequent reimplantation, less soft tissue contracture, less scar adhesion, easy removal of the cement intramedullary nail, and successful infection control.

The time interval between removal of the components and implantation of the revision prosthesis varies widely. Typically, the revision is performed 6 to 12 weeks after the removal of the prosthesis (first stage). The antibiotics should be discontinued 2 weeks before the definitive treatment. Multiple cultures of specimens should be obtained during the revision to confirm the eradication of the infection. The spacer or the tobramycin beads are removed from the joint at that time.

The definitive implants can be either cemented or cementless. Factors reported to be most important in deciding to insert the implant without cement are an age of less than 65 years and thinning of the cortical wall of the femur.[26] A thin cortical wall has been found to be associated with decreased shear strength at the bone-cement interface of revision prostheses.[66] When cemented implants are inserted, antibiotic-impregnated cement (eg, 1.2 g of tobramycin in 40 g of cement) should be used.

Whenever possible, bulky implants are avoided in the knee; a constrained prosthesis is associated with higher rates of infection. Bone defects left after implant removal may have to be treated with large structural allografts. Although some studies have reported increased infection rates with large allografts, the use of such grafts has increased.[67, 68]

Direct versus delayed exchange

A great deal of controversy exists regarding the relative advantages and disadvantages of direct and delayed exchange. The merits and the limitations of the 2 approaches are briefly summarized in Table 3 below.

Table 3. Advantages and Disadvantages of Direct and Delayed Exchange (Open Table in a new window)

Direct Exchange Delayed Exchange
Advantages



  • Less morbidity
  • Reduced cost
  • Improved mechanical stability
  • Less complicated technique
  • Shorter duration of disability
Disadvantages



  • Inability to use sensitive antibiotic to mix with cement while fixation
Contraindications



  • Immunocompromise
  • Major soft tissue or skin defect
  • Gram-negative organisms
  • Actively discharging sinus or overt purulence
Advantages



  • Ability to identify organisms, determine sensitivities, and give adequate antibiotics before reimplantation
  • Ability to repeat debridement if necessary
  • Ability to identify and correct other foci of infection and inciting factors
Disadvantages



  • Technical difficulty resulting from extensive scarring and contracture
  • Hardships of resection arthroplasty
  • Increased cost and hospital stay
  • Delayed rehabilitation

Good results have been obtained with delayed exchange arthroplasty in the treatment of chronic infections: the reported success rate is approximately 85%.[26, 33, 58, 69, 70, 71, 72]

Previous
Next

Antibiotic Therapy

Selection of appropriate agent

The best choice of antibiotic for staphylococcal infection has been defined. Rifampin should be used against sensitive organisms, always in combination with another drug (preferably a quinolone) to prevent the emergence of resistance.[73, 74] Newer quinolones, such as moxifloxacin, levofloxacin, and gatifloxacin, have better activity in vitro against quinolone-susceptible staphylococci than ciprofloxacin, fleroxacin, and ofloxacin do.[27]

Other drugs tried in combination with rifampin include trimethoprim-sulfamethoxazole, minocycline, and fusidic acid. One study showed good results with the rifampin–fusidic acid combination in staphylococcal infections.[75]

Quinopristin-dalfopristin is active against Enterococcus faecium (including vancomycin-resistant enterococci [VRE]) and S aureus (including methicillin-resistant S aureus [MRSA]) but not against Enterococcus faecalis. In a study of 40 patients with orthopedic infections with MRSA treated with this combination, clinical success was reported in 78% and microbial eradication in 69%.[76]

Daptomycin is active against several gram-positive bacteria, including MRSA, vancomycin-resistant S aureus, and VRE.[77]

Linezolid has been used against MRSA, but long-term administration can lead to reversible optic neuropathy, myelosuppression, and irreversible peripheral neuropathy.[78, 79] Data regarding the combination of linezolid with rifampin are lacking. The use of rifampin may be a concern in countries where tuberculosis is endemic; it could help foster the development of resistance in tubercle bacilli.

Trampuz et al recommended antibiotic regimens for various microbial agents causing periprosthetic infections (see Table 4 below).[27]

Table 4. Antibiotic Regimens for Various Pathogens Causing Prosthetic Infections (Open Table in a new window)

Microorganism Antimicrobial Agent1Dosage Route
Staphylococcus aureus or coagulase-negative staphylococci
Methicillin-susceptibleRifampin



plus



(flu)eloxacillin2



450 mg q12h



2 g q6h



PO/IV



IV



For 2 wk, followed by
Rifampin



plus



ciprofloxacin



or



levofloxacin



450 mg q12h



750 mg q12h



750 mg q24h



to 500 mg q12h



PO



PO



PO



PO



Methicillin-resistantFor 2 wk, followed by
Rifampin



plus



ciprofloxacin3



or



levofloxacin3



or



teicoplanin4



or



fusidic acid



or



trimethoprim-sulfamethoxazole



or



minocycline



450 mg q12h



750 mg q12h



750 mg q24h



to 500 mg q12h



400 mg q24h



500 mg q8h



1 forte tablet q8h



100 mg q12h



PO



PO



PO



IV/IM



PO



PO



PO



Streptococcus spp (except S agalactiae)Penicillin G3



or



ceftriaxone



5 million U q6h



2 g q24h



IV



IV



For 2-4 wk, followed by
Amoxicillin750-1000 mg q8hPO
Enterococcus spp (penicillin-susceptible) and S agalactiaePenicillin G



or



ampicillin



or



amoxicillin



plus



aminoglycoside5



5 million U q6h



2 g q4-6h



IV



IV



For 2-4 wk, followed by
Amoxicillin750-1000 mg q8hPO
Enterobacteriaceae (quinolone-susceptible)Ciprofloxacin750 g q12hPO
Nonfermenters (eg, Pseudomonas aeruginosa)Cefepime



or



ceftazidime



plus



aminoglycoside5



2 g q8hIV
For 2-4 wk, followed by
Ciprofloxacin750 g q12hPO
Anaerobes6Clindamycin600 mg q6hPO
For 2-4 wk, followed by
Clindamycin300 mg q6hPO
Mixed infections



(without methicillin-resistant staphylococci)



Amoxicillin-clavulanate



or



piperacillin-tazobactam



or



imipenem



or



meropenem



2.2 g q8h



4.5 g q8h



500 mg q6h



1 g q8h



IV



IV



IV



IV



For 2-4 wk, followed by individual regimens according to antimicrobial susceptibility
PO= orally; IV= intravenously; IM= intramuscularly; forte tablet = trimethoprim 160 mg plus sulfamethoxazole 800 mg; MRSA = methicillin-resistant S aureus.



1. If implant retention or 1-stage exchange is performed, the total duration of antimicrobial treatment is 3 months for hip prosthesis and 6 months for knee prosthesis.



2. In patients with delayed hypersensitivity, cefazolin (2 g q8h IV) may be administered. In patients with immediate hypersensitivity, penicillin should be replaced with vancomycin (1 g q12h).



3. MRSA should not be treated with quinolones, because antimicrobial resistance might emerge during treatment.



4. On the first day of treatment, the teicoplanin dose should be increased to 800 mg IV (loading dose).



5. Aminoglycosides can be administered in a single daily dose.



6. Alternatively, penicillin G (5 million U q6h IV) or ceftriaxone (2 g q24h IV) may be used for gram-positive anaerobes (eg, Propionibacterium acnes), and metronidazole (500 mg q8h IV or PO) for gram-negative anaerobes (eg, Bacteroides spp).



Antibiotic-impregnated cement

The use of antibiotic-impregnated cement has greatly altered the delivery of antibiotic to the infection site. The most commonly used antibiotics are tobramycin, vancomycin, and gentamicin. Some antibiotics (eg, lincomycin and tetracycline) are deactivated when mixed with cement. Rifampin forms a black, tacky composite and hence should not be used.

The recommended antibiotic doses vary, depending on whether the cement is being used as beads or spacers or for fixation of implants. For fixation of implants, 1 g of vancomycin or 1.2 g of gentamicin or tobramycin is the ideal dose; for use in spacers or beads, these doses can be doubled.

Previous
Next

Treatment Options for Special Clinical Situations

Long-term antibiotic suppression

Although there are no strict guidelines regarding the optimal duration and route of antibiotic therapy, intravenous (IV) administration of antibiotics for 6 weeks in doses that achieve a bactericidal concentration of at least 1:8 have proven efficacious in reimplantation protocol studies. A higher drug concentration is needed for bacteria adhering to cement or polyethylene than for suspended bacteria.

Long-term oral antibiotic therapy may be considered in elderly patients who have a short life expectancy and from whom removal of the prosthesis may be extremely difficult. For such therapy to be a worthwhile option, the organism should be of low virulence and susceptible to an oral antibiotic, and the antibiotic should have no serious side effects. Treatment is individualized.

The disadvantages of long-term antibiotic suppression—namely, the emergence of multidrug resistant organisms, the formation of excessive scar tissue, and the progressive loss of bone stock—must be taken into account in the decision-making process.

Arthrodesis

Young patients with a high functional demand and a single joint involvement are ideal candidates for knee arthrodesis. Factors that rule out a revision procedure (eg, loss of extensor mechanism, poor soft tissue cover, systemic immune compromise, and highly virulent organisms) also warrant a knee arthrodesis.

Relative contraindications for arthrodesis include bilateral knee disease, ipsilateral ankle or hip disease, severe segmental bone loss, and amputation in the contralateral extremity.

Excision arthroplasty

Excision or resection arthroplasty (the Girdlestone operation, as it is commonly referred to when done in the hip joint) is performed either as a definitive procedure or as a temporizing measure to buy time for infection control before reimplantation.

As a definitive procedure, excision hip arthroplasty is typically successful at controlling the infection, but many patients are unable to walk without assistive devices, and all have a limp. The patient is left with a painless unstable hip. Many patients are unwilling to accept the problems associated with excision arthroplasty and request reimplantation instead. The proximal femur is preserved as much as possible.

Current indications for excision arthroplasty in an infected knee are few but are considered to include inflammatory arthropathy. A study of 26 patients, 11 of whom had rheumatoid arthritis, showed that 89% were free of infection at an average of 5 years after excision arthroplasty.[80] Functional results were suboptimal: only 15 patients were able to walk independently, and all required walking aids. Only 5 patients had sufficient knee stability to walk without external support; 8 required a knee-ankle-foot orthosis, and 2 used a splint.

Although excision knee arthroplasty usually results in satisfactory resolution of the infection, most patients experience some pain and knee instability and have a limited ability to walk.

Previous
 
Contributor Information and Disclosures
Author

Rajesh Malhotra, MBBS, MS  Professor, Department of Orthopedics, All India Institute of Medical Sciences

Disclosure: Nothing to disclose.

Coauthor(s)

Karthik S Murugappan, MBBS, MS(Orth), DNB, MRCS  Consulting Surgeon, Department of Orthopedics, Flinders Medical Center, Australia

Disclosure: Nothing to disclose.

Chief Editor

William L Jaffe, MD  Clinical Professor of Orthopedic Surgery, New York University School of Medicine; Vice Chairman, Department of Orthopedic Surgery, New York University Hospital for Joint Diseases

William L Jaffe, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Orthopaedic Association, Eastern Orthopaedic Association, and New York Academy of Medicine

Disclosure: Stryker Orthopaedics Consulting fee Speaking and teaching

Additional Contributors

James J McCarthy, MD, FAAOS, FAAP Associate Professor, Consulting Orthopedic Surgeon, Department of Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health

James J McCarthy, MD, FAAOS, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Orthopaedic Association, Limb Lengthening and Reconstruction Society ASAMI-North America, Orthopaedics Overseas, Pediatric Orthopaedic Society of North America, Pennsylvania Medical Society, Pennsylvania Orthopaedic Society, and Philadelphia County Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics. Sep 1995;18(9):871-3. [Medline].

  2. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop Relat Res. Oct 1996;140-5. [Medline].

  3. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. Aug 2005;87(8):1746-51. [Medline].

  4. Urban JA, Garvin KL. Infection after total hip arthroplasty. Curr Opin Orthop. 2001;12:64-70.

  5. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. Oct 2008;23(7):984-91. [Medline].

  6. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. Apr 2007;89(4):780-5. [Medline].

  7. Trampuz A, Piper KE, Jacobson MS, Hanssen AD, Unni KK, Osmon DR. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654-63.

  8. Pakos EE, Trikalinos TA, Fotopoulos AD, Ioannidis JP. Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies--a meta-analysis. Radiology. Jan 2007;242(1):101-8. [Medline].

  9. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am. May 2002;84-A(5):759-62. [Medline].

  10. Zappe B, Graf S, Ochsner PE, Zimmerli W, Sendi P. Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge. Arch Orthop Trauma Surg. Oct 2008;128(10):1039-46. [Medline].

  11. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am. Oct 1999;81(10):1434-45. [Medline].

  12. Dunbar MJ, Richardson G. Minimizing infection risk: fortune favors the prepared mind. Orthopedics. 2011;34(9):e467-9. [Medline].

  13. Smith TK. Nutrition: its relationship to orthopedic infections. Orthop Clin North Am. Jul 1991;22(3):373-7. [Medline].

  14. Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplasty. Dec 1991;6(4):321-5. [Medline].

  15. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res. Jan 2008;466(1):153-8. [Medline].

  16. Surin VV, Sundholm K, Bäckman L. Infection after total hip replacement. With special reference to a discharge from the wound. J Bone Joint Surg Br. Aug 1983;65(4):412-8. [Medline].

  17. Rand JA, Fitzgerald RH Jr. Diagnosis and management of the infected total knee arthroplasty. Orthop Clin North Am. Apr 1989;20(2):201-10. [Medline].

  18. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg. Aug 1973;107(2):206-10. [Medline].

  19. Ritter MA, Campbell ED. Retrospective evaluation of an iodophor-incorporated antimicrobial plastic adhesive wound drape. Clin Orthop Relat Res. Mar 1988;(228):307-8. [Medline].

  20. Johnston DH, Fairclough JA, Brown EM, Morris R. Rate of bacterial recolonization of the skin after preparation: four methods compared. Br J Surg. Jan 1987;74(1):64. [Medline].

  21. Berg-Perier M, Cederblad A, Persson U. Ultraviolet radiation and ultraclean air enclosures in operating rooms: UV-protection, economy, and comfort. J Arthroplasty. 1992;7:457-463.

  22. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed). 1982;10-14:285.

  23. Miner AL, Losina E, Katz JN, Fossel AH, Platt R. Deep infection after total knee replacement: impact of laminar airflow systems and body exhaust suits in the modern operating room. Infect Control Hosp Epidemiol. Feb 2007;28(2):222-6. [Medline].

  24. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA 2nd, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. Oct 1977;59(7):847-55. [Medline].

  25. Petty W, Spanier S, Shuster JJ, Silverthorne C. The influence of skeletal implants on incidence of infection. Experiments in a canine model. J Bone Joint Surg. Oct 1985;67-A:1236-1244.

  26. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. Apr 1996;78(4):512-23. [Medline].

  27. Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs. Feb 2005;6(2):185-90. [Medline].

  28. Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706-15.

  29. Rosenberg AD, Wambold D, Kraemer L, Begley-Keyes M, Zuckerman SL, Singh N, et al. Ensuring appropriate timing of antimicrobial prophylaxis. J Bone Joint Surg Am. Feb 2008;90(2):226-32. [Medline].

  30. Scottish Intercollegiate Network Guidelines. Antibiotic prophylaxis in surgery. 2001. Available at http://www.sign.ac.uk/guidelines/fulltext/45/index.html. Accessed 20 June 2006.

  31. Van Kasteren ME, Gyssens IC, Kullberg BJ, Bruining HA, Stobberingh EE, Goris RJ. Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Working Party on Antibiotic Policies (SWAB). Ned Tijdschr Geneeskd. 2000;144:2049-55.

  32. van Kasteren ME, Manniën J, Ott A, Kullberg BJ, de Boer AS, Gyssens IC. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis. Apr 1 2007;44(7):921-7. [Medline].

  33. Cuckler JM, Starr AM, Alavi A, et al. Diagnosis and management of total joint arthroplasty. Orthop Clin North Am. 1991;22:523-530.

  34. Duff GP, Lachiewicz PF, Kelley SS. Aspiration of the knee joint before revision arthroplasty. Clin Orthop Relat Res. Oct 1996;132-9. [Medline].

  35. Spangehl MJ, Younger SE, Masri BA, et al. Diagnosis of infection following total hip arthroplasty. J Bone Joint Surg Am. 1997;79:1478-158.

  36. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. May 1999;81(5):672-83. [Medline].

  37. Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, et al. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg Am. Jul 2007;89(7):1409-16. [Medline].

  38. Bori G, Soriano A, García S, Mallofré C, Riba J, Mensa J. Usefulness of histological analysis for predicting the presence of microorganisms at the time of reimplantation after hip resection arthroplasty for the treatment of infection. J Bone Joint Surg Am. Jun 2007;89(6):1232-7. [Medline].

  39. Malhotra R, Morgan DAF. Core biopsy to exclude sepsis in failed THA. J Arthroplasty. Jan 2004;19(1):78-87.

  40. Fitzgerald RH Jr. Infected total hip arthroplasty: diagnosis and treatment. JAAOS. 1995;3:3.

  41. Palestro CJ, Kim CK, Swyer AJ, Capozzi JD, Solomon RW, Goldsmith SJ. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med. Dec 1990;31(12):1950-5. [Medline].

  42. Love C, Marwin SE, Tomas MB, Krauss ES, Tronco GG, Bhargava KK. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med. Nov 2004;45(11):1864-71. [Medline].

  43. Mumme T, Reinartz P, Alfer J, Müller-Rath R, Buell U, Wirtz DC. Diagnostic values of positron emission tomography versus triple-phase bone scan in hip arthroplasty loosening. Arch Orthop Trauma Surg. Jun 2005;125(5):322-9. [Medline].

  44. Reinartz P, Mumme T, Hermanns B, Cremerius U, Wirtz DC, Schaefer WM. Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg Br. Apr 2005;87(4):465-70. [Medline].

  45. Nolan DR, Fitzgerald RH Jr, Beckenbaugh RD, Coventry MB. Complications of total hip arthroplasty treated by reoperation. J Bone Joint Surg. Oct 1975;57-A:977-981.

  46. Nelson JP. Deep infection following total hip arthroplasty. J Bone Joint Surg. Dec 1977;59-A:1042-1044.

  47. Hunter G, Dandy D. The natural history of the patient with an infected total hip replacement. J Bone Joint Surg Br. Aug 1977;59(3):293-7. [Medline].

  48. Canner GC, Steinberg ME, Heppenstall RB, Balderston R. The infected hip after total hip arthroplasty. J Bone Joint Surg. Dec 1984;66-A:1393-1399.

  49. Wroblewski BM. One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res. Oct 1986;103-7. [Medline].

  50. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am. Jul 1998;80(7):961-8. [Medline].

  51. Hsieh PH, Shih CH, Chang YH, Lee MS, Shih HN, Yang WE. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am. Sep 2004;86-A(9):1989-97. [Medline].

  52. Lai KA, Shen WJ, Yang CY, Lin RM, Lin CJ, Jou IM. Two-stage cementless revision THR after infection. 5 recurrences in 40 cases followed 2.5-7 years. Acta Orthop Scand. Aug 1996;67(4):325-8. [Medline].

  53. Leunig M, Chosa E, Speck M, Ganz R. A cement spacer for two-stage revision of infected implants of the hip joint. Int Orthop. 1998;22(4):209-14. [Medline].

  54. Collins DN, McKenzie JM. Infections at the site of a hip implant. Successful and unsuccessful management. Clin Orthop Relat Res. Aug 1991;(269):9-15. [Medline].

  55. Hunter GA. The results of reinsertion of a total hip prosthesis after sepsis. J Bone Joint Surg Br. Nov 1979;61-B(4):422-3. [Medline].

  56. James ET, Hunter GA, Cameron HU. Total hip revision arthroplasty: does sepsis influence the results?. Clin Orthop Relat Res. Oct 1982;88-94. [Medline].

  57. Jupiter JB, Karchmer AW, Lowell JD, Harris WH. Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis. J Bone Joint Surg. Feb 1981;63-A:194-200.

  58. McDonald DJ, Fitzgerald RH Jr, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am. Jul 1989;71(6):828-34. [Medline].

  59. Mirra JM, Amstutz HC, Matos M, Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res. Jun 1976;221-40. [Medline].

  60. Clegg J. The results of the pseudarthrosis after removal of an infected total hip prosthesis. J Bone Joint Surg Br. Aug 1977;59(3):298-301. [Medline].

  61. Johnston RC, Crowninshield RD. Roentgenologic results of total hip arthroplasty. A ten-year follow-up study. Clin Orthop Relat Res. Dec 1983;92-8. [Medline].

  62. Powers KA, Terpenning MS, Voice RA, Kauffman CA. Prosthetic joint infections in the elderly. Am J Med. 1990;88(5N):9N-13N.

  63. Chiang ER, Su YP, Chen TH, Chiu FY, Chen WM. Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty. Acta Orthop. Aug 2011;82(4):460-4. [Medline].

  64. Gruninger RP, Tsukayama DT, Wicklund B. Antibiotic impregnated PMMA beads in bone and prosthetic joint infections. In: Gustilo RB, Gruninger RP, Tsukayama DT, eds. Orthopaedic Infections. Philadelphia: WB Saunders; 1989:66-74.

  65. Yoo J, Lee S, Han C, Chang J. The modified static spacers using antibiotic-impregnated cement rod in two-stage revision for infected total knee arthroplasty. Clin Orthop Surg. Sep 2011;3(3):245-8. [Medline].

  66. Dohmae Y, Bechtold JE, Sherman RE, Puno RM, Gustilo RB. Reduction in cement-bone interface shear strength between primary and revision arthroplasty. Clin Orthop Relat Res. Nov 1988;(236):214-20. [Medline].

  67. Engh GA, Ammeen DJ. Use of structural allograft in revision total knee arthroplasty in knees with severe tibial bone loss. J Bone Joint Surg Am. Dec 2007;89(12):2640-7. [Medline].

  68. Sporer SM, O'Rourke M, Chong P, Paprosky WG. The use of structural distal femoral allografts for acetabular reconstruction. Average ten-year follow-up. J Bone Joint Surg Am. Apr 2005;87(4):760-5. [Medline].

  69. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. Jun 1969;51(4):737-55. [Medline].

  70. Weber FA, Lautenbach EEG. Revision of infected total hip arthroplasty. Clin Orthop. 1986;211:108-115.

  71. Sanzén L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties. Two- to nine-year follow-up study. Clin Orthop Relat Res. Apr 1988;165-72. [Medline].

  72. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. Nov 1989;71(5):851-5. [Medline].

  73. Ariza J, Euba G, Murillo O. [Orthopedic device-related infections]. Enferm Infecc Microbiol Clin. Jun-Jul 2008;26(6):380-90. [Medline].

  74. Choong PM, Dowsey MM, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin-based regimen. Acta Orthop. 2007;78(6):755-65.

  75. Aboltins CA, Page MA, Buising KL, Jenney AW, Daffy JR, Choong PF, et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect. Jun 2007;13(6):586-91. [Medline].

  76. Drew RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency- Use Study Group. J Antimicrob Chemother. 2000;46:775-84.

  77. Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004;38:994-1000.

  78. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis. Aug 2004;4(8):528-31. [Medline].

  79. Latronico N, Guarneri B. Critical illness myopathy and neuropathy. Minerva Anestesiol. Jun 2008;74(6):319-23. [Medline].

  80. Falahee MH, Matthews LS, Kaufer H. Resection arthroplasty as a salvage procedure for a knee with infection after a total arthroplasty. J Bone Joint Surg Am. Sep 1987;69(7):1013-21. [Medline].

Previous
Next
 
Final radiograph after stage II revision.
Stage I revision with antibiotic spacer made from mold.
Radiograph of 50-year-old patient for whom bipolar arthroplasty was done elsewhere for displaced fracture of neck of femur. Patient came with severe pain hip 1 year after procedure. Severe osteolysis and superior migration of prosthesis are seen.
Infected total knee arthroplasty with sinus.
Lateral radiograph showing lysis and loosening of prosthesis.
Frankly infected tissue around prosthesis.
Cement spacer application.
Radiograph after stage I revision.
Stage II revision. Bone loss at femoral side; allograft used.
Astemmed femoral prosthesis and allograft used for bone loss.
Final radiograph after stage II revision.
Table 1: Common Pathogens Responsible for Prosthetic Joint Infections
Microorganism Frequency (%)
Coagulase-negative staphylococci30-43
Staphylococcus aureus12-23
Streptococci9-10
Enterococci3-7
Gram-negative bacilli3-6
Anaerobes2-4
Multiple pathogens (polymicrobial)10-12
Unknown10-11
Table 2. Concise Approach to Treatment of Prosthetic Joint Infections
Status of Prosthetic Joint Infection Treatment
Duration of symptoms < 3 wk



and



stable implant



and



absence of sinus tract



and



susceptibility to antibiotics with activity against surface-adhering microorganisms



Débridement with retention
Intact or only slightly damaged soft tissue1-stage exchange
Damaged soft tissue, abscess, or sinus tract2-stage exchange with short interval (2-4 wk), spacer
Microorganism resistant or difficult to treat*2-stage exchange with long interval (6-8 wk), no spacer
Inoperable, debilitated, or bedriddenLong-term suppressive antimicrobial treatment
No functional improvement by exchange of implantImplant removal without replacement
Table 3. Advantages and Disadvantages of Direct and Delayed Exchange
Direct Exchange Delayed Exchange
Advantages



  • Less morbidity
  • Reduced cost
  • Improved mechanical stability
  • Less complicated technique
  • Shorter duration of disability
Disadvantages



  • Inability to use sensitive antibiotic to mix with cement while fixation
Contraindications



  • Immunocompromise
  • Major soft tissue or skin defect
  • Gram-negative organisms
  • Actively discharging sinus or overt purulence
Advantages



  • Ability to identify organisms, determine sensitivities, and give adequate antibiotics before reimplantation
  • Ability to repeat debridement if necessary
  • Ability to identify and correct other foci of infection and inciting factors
Disadvantages



  • Technical difficulty resulting from extensive scarring and contracture
  • Hardships of resection arthroplasty
  • Increased cost and hospital stay
  • Delayed rehabilitation
Table 4. Antibiotic Regimens for Various Pathogens Causing Prosthetic Infections
Microorganism Antimicrobial Agent1Dosage Route
Staphylococcus aureus or coagulase-negative staphylococci
Methicillin-susceptibleRifampin



plus



(flu)eloxacillin2



450 mg q12h



2 g q6h



PO/IV



IV



For 2 wk, followed by
Rifampin



plus



ciprofloxacin



or



levofloxacin



450 mg q12h



750 mg q12h



750 mg q24h



to 500 mg q12h



PO



PO



PO



PO



Methicillin-resistantFor 2 wk, followed by
Rifampin



plus



ciprofloxacin3



or



levofloxacin3



or



teicoplanin4



or



fusidic acid



or



trimethoprim-sulfamethoxazole



or



minocycline



450 mg q12h



750 mg q12h



750 mg q24h



to 500 mg q12h



400 mg q24h



500 mg q8h



1 forte tablet q8h



100 mg q12h



PO



PO



PO



IV/IM



PO



PO



PO



Streptococcus spp (except S agalactiae)Penicillin G3



or



ceftriaxone



5 million U q6h



2 g q24h



IV



IV



For 2-4 wk, followed by
Amoxicillin750-1000 mg q8hPO
Enterococcus spp (penicillin-susceptible) and S agalactiaePenicillin G



or



ampicillin



or



amoxicillin



plus



aminoglycoside5



5 million U q6h



2 g q4-6h



IV



IV



For 2-4 wk, followed by
Amoxicillin750-1000 mg q8hPO
Enterobacteriaceae (quinolone-susceptible)Ciprofloxacin750 g q12hPO
Nonfermenters (eg, Pseudomonas aeruginosa)Cefepime



or



ceftazidime



plus



aminoglycoside5



2 g q8hIV
For 2-4 wk, followed by
Ciprofloxacin750 g q12hPO
Anaerobes6Clindamycin600 mg q6hPO
For 2-4 wk, followed by
Clindamycin300 mg q6hPO
Mixed infections



(without methicillin-resistant staphylococci)



Amoxicillin-clavulanate



or



piperacillin-tazobactam



or



imipenem



or



meropenem



2.2 g q8h



4.5 g q8h



500 mg q6h



1 g q8h



IV



IV



IV



IV



For 2-4 wk, followed by individual regimens according to antimicrobial susceptibility
PO= orally; IV= intravenously; IM= intramuscularly; forte tablet = trimethoprim 160 mg plus sulfamethoxazole 800 mg; MRSA = methicillin-resistant S aureus.



1. If implant retention or 1-stage exchange is performed, the total duration of antimicrobial treatment is 3 months for hip prosthesis and 6 months for knee prosthesis.



2. In patients with delayed hypersensitivity, cefazolin (2 g q8h IV) may be administered. In patients with immediate hypersensitivity, penicillin should be replaced with vancomycin (1 g q12h).



3. MRSA should not be treated with quinolones, because antimicrobial resistance might emerge during treatment.



4. On the first day of treatment, the teicoplanin dose should be increased to 800 mg IV (loading dose).



5. Aminoglycosides can be administered in a single daily dose.



6. Alternatively, penicillin G (5 million U q6h IV) or ceftriaxone (2 g q24h IV) may be used for gram-positive anaerobes (eg, Propionibacterium acnes), and metronidazole (500 mg q8h IV or PO) for gram-negative anaerobes (eg, Bacteroides spp).



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.